CMMI Cybermaturity Platform Builds Board and C-Suite Confidence In Cybersecurity Programs and Investments
The CMMI Institute today announces the CMMI Cybermaturity Platform, a comprehensive enterprise cybersecurity capability and risk assessment platform that provides cybersecurity and senior executives with the evidence and insights to improve cybersecurity resilience.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180416005670/en/
CMMI Institute's new Cybermaturity Platform, an ISACA Cyber Solution, helps enterprises improve cybersecurity resilience and gain confidence in their cybersecurity investments. (Graphic: Business Wire)
The cloud-based platform, an ISACA Cyber Solution, was developed through research and testing with hundreds of CISOs, CIOs, and CSOs in the last year. The platform features custom risk profiling, assessment, gap analyses, and roadmap functions, and is in use across multiple sectors including financial services, healthcare, and manufacturing.
“We believe focusing on risk-based capabilities is foundational to building resilience,” said Kirk Botula, CMMI Institute CEO. “A security program must be suited to the type of business and tailored to the risks at hand. That includes determining whether the processes and mechanisms that support security goals are mature and resilient enough to withstand the dynamic threat landscape –internally and externally.”
The CMMI Cybermaturity Platform addresses industry concerns and organizational challenges cited in several recent reports, including:
- A 2018 McKinsey report, where 75 percent of the risk management experts consider cybersecurity to be a top priority; 16 percent said their companies were well-prepared to deal with cyber-risk;
- ISACA’s 2017 Better Tech Governance is Better for Business statistics, which noted that 87 percent of C-suite professionals and board members lack confidence in cybersecurity initiatives—programs that remains the top corporate governance challenge;
- ISACA’s just-released 2018 State of Cybersecurity Part 1, in which nearly 1 in 3 (31 percent) security professionals says their board hasn’t adequately prioritized security.
In creating the new platform category, the CMMI Cybermaturity architecture measures current and desired maturity levels, providing a prioritized roadmap to deliver:
- Evidence-based risk reduction;
- Capability building—across people, process and technology;
- Relevancy, given the changing threat landscape, through biannual updates of risks and capabilities; and
- Increased board and c-suite confidence, driven by pragmatic, insightful, easy-to-understand reports, aligned to business objectives.
As the only cloud-hosted cybersecurity maturity management application, the CMMI Cybermaturity Platform gives businesses real-time knowledge of best cybersecurity practices, so organizations can make evidence-based decisions on how to improve cybersecurity programs. The platform enables business and technology leaders to assess and view all facets of their cybersecurity program and capabilities through a risk lens to better develop a cohesive cyber strategy.
“To alleviate cybersecurity concerns, we must implement more objective, consistent, and actionable reporting to senior executives and board directors about security, and the CMMI Platform does that,” said Matt Loeb, CGEIT, CAE, FASAE, chairman of the CMMI Board of Managers and ISACA CEO. “Together, ISACA and CMMI now offer a comprehensive approach for enterprises to assess risk, develop an improvement roadmap for the organization, and, via the CSX Training Platform, to train professionals to overcome performance gaps.”
The CMMI Cybermaturity Platform’s assessment generates a unique risk profile, prioritizes the gaps in capabilities, identifies the maturity required to achieve organizational goals, and recommends options to address the gaps. The program defines maturity for people, process and technology and will enable industry benchmarking.
With such data in hand, the CMMI Cybermaturity Platform builds board confidence and trust by aligning strategic objectives with pragmatic insights of security risks. Organizations are provided with the means to be in a constant state of building capability, resiliency and appropriate governance. More information on the path to enterprise cyber resiliency can be found in our white paper, “A Risk-Aware Path to Cybersecurity Resilience and Maturity.”
The CMMI Cybermaturity Platform establishes a framework of best cyber practices which aligns with the leading industry standards, such as NIST CSF, COBIT, ISO, Cloud Security Alliance and dozens more. Further information on the assessment approach and organizational roadmaps to cyber resiliency can be found at cmmiinstitute.com/cybermaturity.
About CMMI ® Institute
A subsidiary of ISACA Enterprises, CMMI Institute (cmmiinstitute.com) is the global leader in the advancement of best practices in people, process, and technology. The Institute provides the tools and support for organizations to benchmark their capabilities and build maturity by comparing their operations to best practices and identifying performance gaps. For over 25 years, thousands of high-performing organizations in a variety of industries, including aerospace, finance, healthcare, software, defense, transportation, and telecommunications, have improved their performance and earned a CMMI maturity level rating and proved they are capable business partners and suppliers.
Nearing its 50th year, ISACA ® (isaca.org ) is a global association helping individuals and enterprises achieve the positive potential of technology. Today’s world is powered by technology, and ISACA equips professionals with the knowledge, credentials, education and community to advance their careers and transform their organizations. ISACA leverages the expertise of its 450,000 engaged professionals in information and cybersecurity, governance, assurance, risk and innovation, as well as its enterprise performance subsidiary, CMMI® Institute, to help advance innovation through technology. ISACA has a presence in more than 188 countries, including more than 215 chapters worldwide and offices in both the United States and China.
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41 | Tiedote
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42 | Tiedote
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00 | Tiedote
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Alps Electric to Exhibit at CES 2019 as Alps Alpine for the First Time14.12.2018 10:58 | Tiedote
Japanese comprehensive electronic components manufacturer Alps Electric Co., Ltd. (TOKYO:6770) (Ota-ku, Tokyo; President: Toshihiro Kuriyama) will exhibit at CES 2019, to open at the Las Vegas Convention and World Trade Center in Las Vegas, Nevada, in the United States on January 8. Alps Electric will be taking part as a new company, Alps Alpine Co., Ltd., for the first time. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181213006022/en/ Alps Alpine's new touch input device for automotive (Graphic: Business Wire) At CES 2019, an exposition of cutting-edge technologies brought together from around the world, Alps Electric will present a variety of technologies in response to the major trends in automotive development referred to as “CASE”—namely connected cars, autonomous driving, sharing and services, and electric vehicles. Making its first appearance at the show as a new company following its business integration with subs
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme